Ind-Swift Labs Q1 PAT jumps 3x; sells Punjab land for Rs 17.5 Cr

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+19.1%Reaction day

₹239.00

prior close

₹266.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+19.3% vs market

Pharmaceuticals peers, median of 164sector+0.1%+19.0% vs sector

On the reaction day the stock moved 19.3 pts more than Nifty Microcap 250 and 19.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.2

10m

+5.6

15m

+5.2

30m

+5.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+19.1-0.2+19.3+0.1+19.0

Next day

+25.7+0.2+25.5-0.5+26.2

+24.1+0.4+23.7+0.1+24.0

+27.2+0.4+26.8-0.5+27.7

+32.0+0.6+31.5-1.1+33.1

+46.4+0.9+45.5-0.7+47.2

+39.3+0.9+38.5-1.2+40.5

15d

+52.5+0.9+51.6-0.8+53.3

+62.8+2.3+60.4+0.9+61.8

+51.5-1.1+52.6-3.1+54.6

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ind-Swift Labs Q1 FY27: Revenue from operations up 21% YoY at Rs 186.08 Cr. Standalone PAT surged to Rs 24.44 Cr from Rs 8.12 Cr; EBITDA jumped to Rs 33.32 Cr from Rs 8.44 Cr. EPS at Rs 2.81. Also approved sale of about 10 acres land in Derabassi, Punjab for Rs 17.50 Crore, found unsuitable for the planned facility. Auditor issued an unqualified review report.

Likely market impact

Strong profit growth and margin expansion signal operational turnaround; land sale monetises an unsuitable asset without core impact.